Abstract
The Oncomine Dx Target Test(Oncomine) is one of next generation sequence tests simultaneously analyze 46 genetic abnormalities including 4 genes approved for companion diagnostic tests for non-small cell lung cancer (NSCLC). The success rates of Oncomine in clinical practice has become an issue. In this report, we evaluated implementation status of Oncomine in our hospital and its usefulness in clinical practice.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
